TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

Sequential Infusion of Mesenchymal Stem Cell for Graft-Versus-Host Disease Prevention in Haploidentical Hematopoietic Stem Cell Transplantation: An Open-Label, Multicenter, Randomized Controlled Clinical Trial.

Han Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.